Depression, Anxiety May Correlate With Disease Activity in Early Rheumatoid Arthritis
This research provides further support to compelling data linking inflammation and depression.
This research provides further support to compelling data linking inflammation and depression.
To effectively treat individuals with radiographic knee OA and comorbid depressive disorder, it is necessary to use a combined treatment strategy of 2 interventions delivered in parallel to simultaneously target each condition.
Based on these results, clinicians should consider assessing functional and mental health states before biologic tapering.
Abatacept may offer good efficacy for improving bone mineral density at the femoral neck in patients with rheumatoid arthritis.
Adalimumab was well tolerated and associated with persistent uveitis improvement in most cases.
The FDA has expanded the approval of mepolizumab for treating eosinophilic granulomatosis with polyangiitis, which causes vasculitis.
As of November 21, 2017, the FDA received 194 adverse event reports about the unapproved osteoarthritis treatment Limbrel.
Gout medication febuxostat (Uloric) was associated with an increased risk of heart-related death and death from all causes.
Inflammation shown on MRI of the sacroiliac joint (MRI-SI) is prevalent in axSpA (±30%), but the specificity is not well known.
Rheumatology specialists should be aware of the clinical features of SSc-PAH, as well as the tools available to facilitate a prompt, accurate diagnosis.